Psilocybin spores used to be intensively researched by multiple research groups at a variety of prestigious universities in the 1970s and for some time during the 1980s as well, but then the compound that gave magic mushrooms their psychedelic effects was included in the list of controlled substances, which has halted and or at least very significantly slowed down the process of researching the mushrooms. The tendencies to decriminalize and legalize the use of psychedelic mushrooms have came about parallel with the growing interest of the scientific research community in how magic mushrooms can be safely used and what conditions can the use of the mushrooms improve or even cure.
What scientists know already is that administering very small doses of magic mushrooms (a technique known as microdosing) has brought about beneficial effects for sufferers of depression, anxiety and post-traumatic stress disorder without inducing hallucinations or other alterations in sensory perceptions. Providers of psilocybe spores say that a single high concentration spore syringe includes hundreds of thousands of mushroom spores offering countless research opportunities. The research into the effects of these mushrooms is likely to continue in the direction of finding other affections that can be safely and efficiently treated or ameliorated with the help of magic mushrooms. Another potential direction for research is the identification of the ideal dose when specific effects are to be achieved.